9th Annual Biomarkers Congress

View Profile


No Speaking/Presenting-Abstract/Poster at Mtg




Site wide Speaking/Presenting-Abstract/Poster at Mtg

Presentation Event Month, Year
Multiple Myeloma 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma February, 2011
MoAbs in Multiple Myeloma 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma February, 2011
Highlights in the Management of Elderly Patients With Newly Diagnosed Myeloma 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma February, 2011
Debate: For newly diagnosed SCTeligible myeloma patients the most appropriate induction therapy is: Great Debates and Updates in Hematologic Malignancies April, 2010
Debate: What is the most appropriate frontline regimen for transplant ineligible myeloma patients? Great Debates and Updates in Hematologic Malignancies April, 2010
Debate: Since novel agents appear to abrogate the negative impact of poor risk cytogenetics, are cytogenetics by FISH still a necessary part of risk stratification for newly diagnosed multiple myeloma patients? Great Debates and Updates in Hematologic Malignancies April, 2010
Case-Based Cancer Medicine: Supportive Care 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine October, 2009
Later 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine October, 2009
Hematologic Malignancies Debate 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine October, 2009
Transplant-Ineligible Multiple Myeloma 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine October, 2009
Case-Based Cancer Medicine: Hematologic Malignancies 13th Annual Fall Oncology Conference: Clinical Challenges in Cancer Medicine October, 2009

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.